Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · IEX Real-Time Price · USD
0.469
-0.013 (-2.61%)
At close: Apr 12, 2024, 4:00 PM
0.479
+0.010 (2.09%)
After-hours: Apr 12, 2024, 4:22 PM EDT

Daré Bioscience Stock Forecast

DARE's stock price has decreased by -50.65% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Daré Bioscience stock has a target of 6.00, which predicts an increase of 1,178.23% from the current stock price of 0.47.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $6.00 $6.00 $6.00 $6.00
Change +1178.2% +1178.2% +1178.2% +1178.2%

Analyst Ratings

According to 1 stock analyst, the rating for DARE is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '23Dec '23Jan '24Feb '24Mar '24Apr '24
Strong Buy 222221
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222221

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6
Strong Buy Reiterates $6 +1,178.23% Apr 1, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$7$6
Strong Buy Maintains $7$6 +1,178.23% Nov 10, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +1,391.27% Aug 11, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +1,391.27% Jul 13, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +1,391.27% Jun 6, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
7.10M
from 2.81M
Increased by 152.93%
Revenue Next Year
34.03M
from 7.10M
Increased by 379.22%
EPS This Year
-0.19
from -0.35
EPS Next Year
0.17
from -0.19
Year 2019202020212022202320242025202620272028
Revenue
---10.00M2.81M7.10M34.03M64.53M184.40M300.74M
Revenue Growth
-----71.92%152.93%379.22%89.59%185.78%63.09%
EPS
-0.97-0.91-0.63-0.37-0.35-0.190.170.310.881.43
EPS Growth
-------79.41%181.97%62.79%
No. Analysts -----75444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 17.9M 62.5M 119.4M 225.2M 372.6M
Avg 7.1M 34.0M 64.5M 184.4M 300.7M
Low n/a 7.1M 12.6M 141.8M 211.7M

Revenue Growth

Revenue Growth 20242025202620272028
High
535.7%
779.9%
250.8%
249.1%
102.1%
Avg
152.9%
379.2%
89.6%
185.8%
63.1%
Low -
-0.4%
-63.1%
119.7%
14.8%

EPS Forecast

EPS 20242025202620272028
High -0.09 0.56 0.33 1.00 1.63
Avg -0.19 0.17 0.31 0.88 1.43
Low -0.26 -0.10 0.29 0.75 1.23

EPS Growth

EPS Growth 20242025202620272028
High - -
87.7%
220.6%
85.5%
Avg - -
79.4%
182.0%
62.8%
Low - -
69.6%
142.6%
39.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.